Italia markets open in 8 hours 13 minutes

Ekso Bionics Holdings, Inc. (0IFR.L)

LSE - LSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
1,2700-0,0564 (-4,25%)
Alla chiusura: 05:56PM BST
Schermo intero
Chiusura precedente1,3264
Aperto1,3044
Denaro0,0000 x N/D
Lettera0,0000 x N/D
Min-Max giorno1,2700 - 1,3044
Intervallo di 52 settimane0,7070 - 3,1000
Volume1.316
Media Volume1.151
Capitalizzazione901.476
Beta (5 anni mensile)1,64
Rapporto PE (ttm)N/D
EPS (ttm)-0,9260
Prossima data utili25 apr 2024 - 29 apr 2024
Rendimento e dividendo (futuro)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    Ekso Bionics Supports Centers for Medicare & Medicaid Services (CMS) Proposed Rule to Include Personal Exoskeletons within a Medicare Benefit Category

    SAN RAFAEL, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, supports the Centers for Medicare & Medicaid Services (“CMS”) proposal to include personal exoskeletons in the Medicare benefit category for braces in the updated 2024 Home Health Prospective Payment System Rate. “This newly proposed rule is highly relevant for our business and individuals with a spinal cor

  • GlobeNewswire

    Ekso Bionics Reports Record Revenues of $4.7 Million in Second Quarter 2023

    Record number of EksoHealth devices booked in second quarter 2023SAN RAFAEL, Calif., July 27, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three and six months ended June 30, 2023. Recent Highlights and Accomplishments Achieved record revenues of $4.7 million in the second quarter of 2023, an increase of 36% year-over-yearBooked a total of

  • GlobeNewswire

    Ekso Bionics to Report Second Quarter 2023 Financial Results on July 27, 2023

    SAN RAFAEL, Calif., July 20, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso Bionics”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the second quarter 2023 after the close of trading on Thursday, July 27, 2023. Management will host a conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to discuss the financial results and recent business develop